Article
RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes
8 Apr 2023
Abstract excerpt
Adeno-associated virus (AAV)-based gene therapy could be facilitated by the development of molecular switches to control the magnitude and timing of expression of therapeutic transgenes. RNA interference (RNAi)-based approaches hold unique potential as a clinically proven modality to pharmacologically regulate AAV gene dosage in a sequence-specific manner. We present a generalizable RNAi-based rheostat wherein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
